Navigation Links
CFO of China Yingxia Emphasizes Growth in Organic and Health Food Segment in Interview by The Wall Street Transcript
Date:10/20/2008

HARBIN, China, Oct. 20 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the health and nutritional food industry engaged in the development, manufacture and distribution of nutritional food products, dietary supplements, and raw cactus plants in the People's Republic of China ("PRC"), today announced that the Company's Chief Financial Officer Ren Hu was interviewed by the Wall Street Transcript to discuss the Company's growth strategy involving its organic and health food business. The interview was published October 20, 2008.

In the interview, Mr. Hu stated that the demand for organic and health food in China is propelled by the increasing disposable income of Chinese urbanites, along with concerns over food safety. China Yingxia has actively focused on growing its nutritional food segment to address this demand. The recent acquisition of a soy milk production facility in Shanghai was a step in this direction, as it equipped the Company with advanced food processing technology for the production of soy milk and soy yogurt.

On addressing the recent scandal involving contaminated cow's milk in China, Mr. Hu considered it to be an opportunity for China Yingxia, since the Company's products are soybean based milk and yogurt, while the majority of the tainted products were derived from cow's milk. The Company's integrated business model and rigid quality control procedures also prevent harmful substances from entering the production process. Soy milk is believed to have more health benefits and a scandal like this may urge more consumers to look for alternatives to cow's milk. China Yingxia will start a marketing campaign to position the Company's organic and health food products attractively to the consumers.

"China Yingxia follows two main strategies to expand its market," Mr. Hu stated in the interview. "The first is to expand the distrib
'/>"/>

SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of Chinas Ministry of Science and Technology
2. China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
3. China Bio Energy Holdings Group Announces Financing and Exercise of Warrants
4. China-Biotics, Inc. Retains KPMG for the Implementation of Sarbanes-Oxley Act Section 404
5. China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xian Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009
6. China-Biotics, Inc. Approved to List on the Nasdaq Global Market
7. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
8. China Medicine to Showcase Bethin Weight Loss Product at 2008 Natural Products Expo East Trade Show
9. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
10. China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
11. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 The laboratory ... that has witnessed a number of technological advancements due ... regulatory requirements, growing need to integrate healthcare systems, and ... ease challenges in system integration. Key players in the ...
(Date:1/22/2015)... January 22, 2015 Dr. Greg Leyer of ... annual Scripps Natural Supplements Pre-Conference seminar on probiotics in San ... an annual continuing education conference for health care professionals. This ... the topic of probiotics in health. Dr. Leyer spoke about ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... Technology to Find a Faster, More Accurate ... 1 ChemImage, ( www.chemimage.com ) today ... Breath, LLC ( www.nextbreath.net ), a leading ... ChemImage,s Raman Chemical Imaging for bioequivalence applications ...
... PETACH TIKVA, Israel, April 1 NexGen Biofuels,Ltd. ... a non-binding,Letter of Intent with World Venture Management ... ("WVM" ) and Mac Bioventures, Inc. The transaction,includes ... relating to its Real,Estate acquisitions and asset management ...
... 1 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), ... and oils in plant seeds, provides an ... insulin program. In December 2008, SemBioSys announced ... to license rights to SemBioSys, proprietary plant-produced ...
Cached Biology Technology:ChemImage and Next Breath Structure Partnership to Validate Bioequivalence Testing for Nasal Spray Suspensions 2ChemImage and Next Breath Structure Partnership to Validate Bioequivalence Testing for Nasal Spray Suspensions 3NexGen Biofuels Ltd Signs Letter of Intent for the Purchase of World Venture Management, Inc. Assets and the Sale of its Current Business 2SemBioSys provides update on insulin program 2SemBioSys provides update on insulin program 3
(Date:1/22/2015)... CHARLOTTE, N.C. , Jan. 22, 2015 Infinisource has ... introduction of the G2 model. The G2 sets a higher ... company,s iSolved human capital management solution. With plug-and-play installation, touch ... G2 time clock provides a robust time collection solution for ...
(Date:12/22/2014)... Dec. 22, 2014  The 2014 Holiday Season may be ... Market Intelligence reports that the long anticipated floodgates for ... intensifying demand for smart phones, tablets, and wearable mobile ... of 2.5 billion users with nearly 4.8 billion biometric ...
(Date:12/19/2014)... LAS VEGAS , Dec. 18, 2014   LaunchKey ... built for the post-password and Internet of Things era, ... seed funding. The venture round was led by Metamorphic ... Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has ...
Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... Mass. CellThera, a biotechnology company located in ... at Gateway Park, has received a contract from ... to extend its research program in tissue regeneration. ... is part of WPI,s Bioengineering Institute (BEI), and ...
... the Helmholtz scientists and their clinical partners want to ... disease and gain perspectives for early diagnosis and therapy. ... online in the journal Nature Genetics . ... (QT Interval and Sudden Cardiac Death), Dr. Arne Pfeufer ...
... are used to thinking of heart disease as a product ... eat and how much we exercise. There is another road ... increase in particulate air pollution is associated with an increase ... relatively new field of environmental cardiology -- a field that ...
Cached Biology News:CellThera and WPI advance in regeneration study 2Genetic risk factors identified for sudden cardiac death 2Genetic risk factors identified for sudden cardiac death 3Inhaling a heart attack: How air pollution can cause heart disease 2Inhaling a heart attack: How air pollution can cause heart disease 3
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Anti-Mouse C-10, Biotin (Polyclonal) (rabbit IgG)...
Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
... The FastPlax Antibody is used to ... on the surface of infected cells as ... the basis of the FastPlax Titer Kit, ... just 25-48 hours. The FastPlax ...
Biology Products: